Passage BioPASG
13F holders, Q2 2024 (June 30)At the end of Q2 2024, 45 institutions reported holding Passage Bio Inc. (PASG) in their 13F filings, down 6 from Q1 2024. 3 opened new positions and 9 sold out. The largest holders were Orbimed Advisors LLC ($8.0M), Vestal Point Capital, LP ($4.8M) and Lynx1 Capital Management LP ($4.0M). 3 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio), Israel Englander (0.0% of Millennium Management's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Passage Bio Inc.
- CUSIP
- 702712100
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $1K |
| Exits | 9 | $559K |
All 13F filers, Q1 2024 → Q2 2024: 1,828,709 shares bought and 1,854,309 shares sold, net −25,600 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 45 holders
| Orbimed Advisors LLC | 0.16% | No change | 10,124,576 | $8.0M |
| Vestal Point Capital, LP | 0.36% | Add +34.5% | 6,052,000 | $4.8M |
| Lynx1 Capital Management LP | 1.45% | Add +4.4% | 5,057,629 | $4.0M |
| Versant Venture Management, LLC | 4.14% | Reduce -18.8% | 4,026,417 | $3.2M |
| New Leaf Venture Partners, L.L.C. | 2.41% | No change | 2,497,922 | $2.0M |
| Erste Asset Management GmbH | 0.03% | No change | 2,455,800 | $2.0M |
| Vanguard Group Inc. | 0.00% | No change | 2,071,538 | $1.6M |
| Tang Capital Management LLC | 0.12% | No change | 1,500,000 | $1.2M |
| Renaissance Technologies | 0.00% | Reduce -6.6% | 1,125,574 | $894K |
| Acadian Asset Management LLC | 0.00% | No change | 961,271 | $762K |
| BlackRock Inc. | 0.00% | Reduce -11.4% | 817,529 | $649K |
| Millennium Management | 0.00% | Reduce -13.3% | 750,926 | $596K |
| Bridgeway Capital Management, LLC | 0.01% | No change | 556,142 | $442K |
| Acuitas Investments, LLC | 0.20% | Add +0.5% | 471,812 | $375K |
| Geode Capital Management, LLC | 0.00% | Add +12.2% | 431,110 | $342K |
| Affinity Asset Advisors, LLC | 0.04% | No change | 264,266 | $210K |
| Fiduciary Trust Co | 0.00% | No change | 215,000 | $171K |
| Citadel Advisors | 0.00% | Reduce -28.6% | 158,261 | $126K |
| RBF Capital, LLC | 0.01% | No change | 142,807 | $113K |
| State Street Corp. | 0.00% | No change | 123,873 | $98K |
| Two Sigma Investments, LP | 0.00% | Reduce -48.4% | 103,854 | $82K |
| Marquette Asset Management, LLC | 0.01% | No change | 85,500 | $68K |
| Northern Trust Corp. | 0.00% | Reduce -23.4% | 64,512 | $51K |
| DLK Investment Management, LLC | 0.02% | No change | 64,000 | $51K |
| Goldman Sachs Group Inc. | 0.00% | Add +1.0% | 27,233 | $22K |
| Cresset Asset Management, LLC | 0.00% | No change | 23,725 | $19K |
| HighTower Advisors, LLC | 0.00% | Reduce -1.1% | 21,512 | $17K |
| FMR LLC | 0.00% | Reduce -0.1% | 21,054 | $17K |
| XTX Topco Ltd | 0.00% | Reduce -60.3% | 17,039 | $14K |
| Morgan Stanley | 0.00% | Reduce -2.9% | 13,442 | $11K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +38732.3% | 13,203 | $10K |
| Barclays PLC | 0.00% | No change | 13,153 | $10K |
| Royal Bank of Canada | 0.00% | Add +38.6% | 693 | $1K |
| UBS Group AG | 0.00% | New | 1,146 | $910 |
| Federated Hermes, Inc. | 0.00% | No change | 783 | $622 |
| Rhumbline Advisers | 0.00% | No change | 783 | $621 |
| Global Retirement Partners, LLC | 0.00% | New | 400 | $318 |
| Bank of America Corp. | 0.00% | Add +36600.0% | 367 | $291 |
| JPMorgan Chase & Co. | 0.00% | No change | 273 | $217 |
| LRI Investments, LLC | 0.00% | No change | 225 | $179 |
| Harbour Investments, Inc. | 0.00% | New | 60 | $48 |
| Group One Trading LLC | 0.00% | No change | 47 | $37 |
| Qube Research & Technologies Ltd | 0.00% | No change | 4 | $4 |
| Cwm, LLC | 0.00% | No change | 5 | $0 |
| Tsfg, LLC | 0.00% | No change | 100 | $0 |
"% of holder's portfolio" is PASG's weight in each manager's 13F, not the share of Passage Bio Inc. the manager owns.